Use of Vivostat PRF® in Acanthamoeba keratitis

Rom J Ophthalmol. 2020 Apr-Jun;64(2):222-225.

Abstract

We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in medical literature in which Vivostat PRF® is used as part of Acanthamoeba keratitis treatment.

Keywords: Acanthamoeba; Vivostat PRF®; keratitis.

Publication types

  • Case Reports

MeSH terms

  • Acanthamoeba Keratitis / therapy*
  • Adult
  • Contact Lenses / adverse effects*
  • Equipment Design
  • Eye Infections, Parasitic / therapy*
  • Humans
  • Male
  • Visual Acuity*